NewsHK
Veeva Systems disclosed on September 30 that more than 175 emerging biotechnology companies have adopted Veeva Basics to build their technology infrastructure.
The move signals an effort to secure a foothold with early-stage firms before they scale their operations.
The platform, built on the Veeva Vault Platform, offers ready-made, validated tools covering clinical, regulatory, quality, medical, and commercial areas.
Veeva Systems states that clients can deploy these systems within weeks and add features as their needs evolve.
Keep reading